SCHEMBL14506258

SCHEMBL14506258

CC(C)c1c(C(C)(C)C)c(O)nc2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.38
▸ ELANE P08246 1/20 0.37
▸ ERN1 O75460 1/20 0.36
▸ AHR P35869 1/20 0.36
▸ RAB9A P51151 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ TSHR P16473 1/20 0.35
▸ GPR3 P46089 1/20 0.34
▸ DHODH Q02127 3/20 0.34
▸ TLR7 Q9NYK1 2/20 0.34
▸ PDE10A Q9Y233 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ POLB P06746 2/20 0.33
▸ TLR8 Q9NR97 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ HMGCR P04035 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14506374 0.81 ATM (0.43) ATMELANEERN1RAB9AMEN1
SCHEMBL13451644 0.78 PDE10A (0.41) ERN1MEN1KMT2AMAPTTSHR
SCHEMBL8879814 0.75 GCGR (0.41) ELANERAB9AGAAKMT2AMAPT
SCHEMBL8877348 0.75 PDE10A (0.50) MEN1KMT2ATSHRDHODHPDE10A
SCHEMBL23682827 0.75 ERN1 (0.54) ERN1MEN1GAAKMT2AMAPT
SCHEMBL1102408 0.74 KDM4E (0.50) ATMRAB9AGAAKMT2AMAPT
SCHEMBL14625667 0.74 KDM4E (0.46) ATMELANEERN1RAB9AMEN1
SCHEMBL14533531 0.74 GCGR (0.43) ELANEMEN1GAAKMT2AMAPT
SCHEMBL8878762 0.73 ERN1 (0.53) ELANEERN1RAB9AMEN1NPC1
SCHEMBL7127697 0.71 GPR3 (0.50) ERN1MEN1GAAKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070105884-A1 Opiate analogs selective for the delta-opioid receptor WELSH WILLIAM J 2007-05-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105884-A1 Opiate analogs selective for the delta-opioid receptor OPRM1, OPRD1, OPRK1 ATM 4464/4885ELANE 1833/4885ERN1 976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback